Category: In Vitro Diagnostics
In Vitro Diagnostics market research reports by Nova One Advisor
-
U.S. Oncology Molecular Diagnostics Market (By Type: Breast Cancer, Liver Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Other Cancer, By Technology; PCR, Sequencing, In Situ Hybridization, INAAT, Chips and Microarrays, Mass Spectrometry, TMA, Others; By Product, Reagents, Instruments, Others)) - Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033
The U.S. oncology molecular diagnostics market size was estimated at USD 0.85 billion in 2023 and is projected to hit around USD 2.74 billion by 2033, growing at a CAGR of 12.41% during the forecast period from 2024 to 2033. U.S. Oncology Molecular Diagnostics Market Key Takeaways By type, the breas ... Read More
-
Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Workflow (NGS Pre-sequencing, NGS Data Analysis), By Technology, By Application, By End Use, By Region, And Segment- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global clinical oncology next generation sequencing market size was estimated at USD 787.91 million in 2023 and is projected to hit around USD 3,232.18 million by 2033, growing at a CAGR of 15.16% during the forecast period from 2024 to 2033. Key Takeaways: North America dominated the market in ... Read More
-
U.S. RFID in Healthcare Market Size, Share & Trends Analysis Report By Product (Systems & Software, Tags), By Application (Blood Tracking, Patient Tracking, Pharmaceutical Tracking),- Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033
U.S. RFID in Healthcare Market Size and Research The U.S. RFID in healthcare market size was exhibited at USD 2.25 billion in 2023 and is projected to hit around USD 10.79 billion by 2033, growing at a CAGR of 16.97% during the forecast period 2024 to 2033. U.S. RFID In Healthcare Market Key Takeawa ... Read More